Coherent Market Insights published a report, titled, “Diagnostic Radiopharmaceuticals and Contrast Media Market, By Radiopharmaceuticals ((by Type of Imaging Modality (SPECT and PET) and by Application (Diagnostic Application and Therapeutic Application)), By Contrast Media ((by Procedure (X-Ray/Computed Tomography (CT), Magnetic Resonance Imaging (MRI), Ultrasound) and by Application (Cardiovascular Disease, Oncology, Gastrointestinal Disorders, Neurological Disorders, and Other Indications)), and By Geography (North America, Europe, Asia Pacific, Latin America, and Middle East & Africa)- Size, Share, Outlook, and Opportunity Analysis, 2023 – 2030” The global diagnostic radiopharmaceuticals and contrast media market was valued at US$ 6,434.9 Million in 2022 and is forecast to reach a value of US$ 10,140.7 Million by 2030 at a CAGR of 5.8% between 2023 and 2030.
Request Sample Copy of this Report: https://www.coherentmarketinsights.com/insight/request-sample/5666
Diagnostic Radiopharmaceuticals are molecules that contain a drug and a radioisotope that is targeted to a specific tissue or organ for the diagnosis and treatment of disorders like cancer, cardiovascular disease, and hyperthyroidism. Radiopharmaceuticals are widely utilized as biomarkers for certain molecular procedures that identify the beginning or progression of disease in a process known as molecular imaging.
Contrast Media are used in medical imaging such as CT, PET/CT, MRI, and ultrasound to increase the quality of the image. Their value has long been acknowledged, as evidenced by their widespread use in radiology departments around the world.
📚 Some of the companies that are profiled in this report are: Siemens Healthineers, Nordion Inc., Lantheus Holdings Inc., Guerbet Group, GE Healthcare, Curium, Bracco Imaging SpA, Bayer AG, Cardinal Health Inc., and NTP Radioisotopes SOC Ltd.
- Global Diagnostic Radiopharmaceuticals and Contrast Media Market, By Radiopharmaceuticals
- By Type of Imaging Modality:
- By Application
- Diagnostic application
- Therapeutic application
- By Type of Imaging Modality:
- Global Diagnostic Radiopharmaceuticals and Contrast Media Market, By Contrast Media
- By Procedure
- X-Ray/Computed Tomography (CT)
- Magnetic Resonance Imaging (MRI)
- By Application
- Cardiovascular Disease
- Gastrointestinal Disorders
- Neurological Disorders
- Other Indications
- By Procedure
- Global Diagnostic Radiopharmaceuticals and Contrast Media Market, By Geography
- North America
- Asia Pacific
- Latin America
- Middle East & Africa
Get Exclusive Purchase Now to Access @ https://www.coherentmarketinsights.com/insight/buy-now/5666
📚 Key Drivers and Restraints of Diagnostic Radiopharmaceuticals & Contrast Media Market
The acceptance of contrast media would improve with technological advancements that result in efficient workflow.
Technology is one of the main forces behind contrast media. Contrast media injectors have substantially changed throughout time, going from manual injection systems to automated ones. The majority of market participants concentrate on creating effective injectors with improved capabilities, including control over contrast media flow, built-in patient safety, and cost reduction.
Increased usage of data management systems and ensuring optimal dosage in collaboration with quick medical imaging scanners are additional issues. These characteristics allow for effective workflows, which raises the acceptance of these contrast media. Switching from single to twin head injectors and prefilled & syringe less injectors are two current trends in the design and functionality of the contrast media injectors.
Rise in awareness about accurate diagnosis
The rise in cancer and cardiovascular disease cases around the world highlights the need for an effective diagnostic method that is both accurate and affordable. Due to their simplicity of use and great accuracy, radioisotope-based molecular imaging methods are becoming more and more common.
Radiopharmaceuticals are used in over 100,000 diagnostic procedures daily throughout the world. According to the Australian Nuclear Science and Technology Organization (ANSTO), nuclear imaging and therapy required about 60 million doses of technetium-based radiopharmaceuticals worldwide in 2016.
📚 The major points covered in the table of contents:
Introduction to the Diagnostic Radiopharmaceuticals And Contrast Media market and its significance in brain science and healthcare.
In-depth analysis of market dynamics, trends, and challenges influencing the Diagnostic Radiopharmaceuticals And Contrast Media sector.
Analysis of Leading Players’ Strategies:
Examination of strategies employed by key players to advance research, technologies, and applications in Diagnostic Radiopharmaceuticals And Contrast Media.
Regional Growth Analysis:
Insights into regional variations in the adoption and application of Diagnostic Radiopharmaceuticals And Contrast Media research and therapies.
Forecasting the market’s trajectory based on current trends, research outcomes, and technological advancements.
Ask Here for Customization Report @ https://www.coherentmarketinsights.com/insight/request-customization/5666
📚 Why Choose Coherent Market Insights?
☛ Identified business opportunities – Our market research report can be used to analyze potential markets and new products. It can give information about customer needs, preferences, and attitudes. Also, it compare products and services.
☛ A clear understanding of your customers – A market report gives company’s marketing department an in-depth picture about customers’ needs and wants. This knowledge can be used to improve products, prices, and advertising.
☛ Clear data-driven insights – Our Market research encompasses a wide range of activities, from determining market size and segment to forecasting demand, and from identifying competitors to monitoring pricing. All of these are quantified and measurable which means that gives you a clear path for building unique decisions based on numbers.
Check Out More Report:
Coherent Market Insights is a global market intelligence and consulting organization focused on assisting our plethora of clients achieve transformational growth by helping them make critical business decisions. We are headquartered in India, having sales office at global financial capital in the U.S. and sales consultants in United Kingdom and Japan. Our client base includes players from across various business verticals in over 57 countries worldwide. We create value for clients through our highly reliable and accurate reports. We are also committed in playing a leading role in offering insights in various sectors post-COVID-19 and continue to deliver measurable, sustainable results for our clients.
Coherent Market Insights Pvt Ltd,
533 Airport Boulevard, Suite 400, Burlingame, CA 94010, United States
📞United States of America: +1-206-701-6702
📞United Kingdom: +44-020-8133-4027